77 related articles for article (PubMed ID: 28358435)
1. Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
Ikeda Y; Kiyotani K; Yew PY; Sato S; Imai Y; Yamaguchi R; Miyano S; Fujiwara K; Hasegawa K; Nakamura Y
Oncol Rep; 2017 May; 37(5):2603-2610. PubMed ID: 28358435
[TBL] [Abstract][Full Text] [Related]
2. High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.
Guo J; Tang B; Fu J; Zhu X; Xie W; Wang N; Ding Z; Song Z; Yang Y; Xu G; Xiao X
Cell Oncol (Dordr); 2024 Apr; 47(2):573-585. PubMed ID: 37847338
[TBL] [Abstract][Full Text] [Related]
3. Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.
John J; Chen SMY; Woolaver RA; Ge H; Vashisht M; Huang Z; Chen Z; Wang JH
Front Immunol; 2023; 14():1100520. PubMed ID: 37051229
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.
Kidman J; Zemek RM; Sidhom JW; Correa D; Principe N; Sheikh F; Fear VS; Forbes CA; Chopra A; Boon L; Zaitouny A; de Jong E; Holt RA; Jones M; Millward MJ; Lassmann T; Forrest ARR; Nowak AK; Watson M; Lake RA; Lesterhuis WJ; Chee J
Oncoimmunology; 2024; 13(1):2345859. PubMed ID: 38686178
[TBL] [Abstract][Full Text] [Related]
5. Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification.
Chen Y; You S; Li J; Zhang Y; Kokaraki G; Epstein E; Carlson J; Huang WK; Haglund F
Front Immunol; 2021; 12():788959. PubMed ID: 35069566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer.
Horeweg N; de Bruyn M; Nout RA; Stelloo E; Kedziersza K; León-Castillo A; Plat A; Mertz KD; Osse M; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; van der Steen-Banasik EM; Smit VT; Creutzberg CL; Bosse T; Nijman HW; Koelzer VH; Church DN
Cancer Immunol Res; 2020 Dec; 8(12):1508-1519. PubMed ID: 32999003
[TBL] [Abstract][Full Text] [Related]
7. Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer.
Kim T; Lim H; Jun S; Park J; Lee D; Lee JH; Lee JY; Bang D
Sci Rep; 2023 Nov; 13(1):20485. PubMed ID: 37993659
[TBL] [Abstract][Full Text] [Related]
8. Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.
Tsuji T; Eng KH; Matsuzaki J; Battaglia S; Szender JB; Miliotto A; Gnjatic S; Bshara W; Morrison CD; Lele S; Emerson RO; Wang J; Liu S; Robins H; Lugade AA; Odunsi K
Oncotarget; 2020 Jul; 11(27):2669-2683. PubMed ID: 32676168
[TBL] [Abstract][Full Text] [Related]
9. Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study.
Zou X; Shen J; Zhang H; Kong F; Jin X; Zhang L
Medicine (Baltimore); 2024 May; 103(19):e38129. PubMed ID: 38728458
[TBL] [Abstract][Full Text] [Related]
10. Targeted spatial proteomic analysis of CD8
Altunbulakli C; Jimenez DG; Askmyr D; Sobti A; Swoboda S; Greiff L; Lindstedt M
Front Oncol; 2023; 13():1253418. PubMed ID: 38044986
[TBL] [Abstract][Full Text] [Related]
11. TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.
Lecuelle J; Boidot R; Mananet H; Derangère V; Albuisson J; Goussot V; Arnould L; Tharin Z; Ray Coquard I; Ghiringhelli F; Truntzer C; Fumet JD
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503204
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.
Nguyen PC; Nguyen T; Wilson C; Tiong IS; Baldwin K; Nguyen V; Came N; Blombery P; Westerman DA
Br J Haematol; 2024 Mar; 204(3):910-920. PubMed ID: 38098188
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients.
Proppe L; Jagomast T; Beume S; Klapper L; Gitas G; Köster F; Perner S; Rody A; Ribbat-Idel J; Hanker LC
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7155-7164. PubMed ID: 36884115
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
[TBL] [Abstract][Full Text] [Related]
15. Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment.
Nakad Borrego S; Lengyel E; Kurnit KC
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139624
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma.
Geng R; Song J; Zhong Z; Ni S; Liu W; He Z; Gan S; Huang Q; Yu H; Bai J; Liu J
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884444
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
Pei LP; Zhang YZ; Li GY; Sun JL
Front Genet; 2022; 13():890591. PubMed ID: 35719366
[No Abstract] [Full Text] [Related]
18. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
Paillet J; Plantureux C; Lévesque S; Le Naour J; Stoll G; Sauvat A; Caudana P; Tosello Boari J; Bloy N; Lachkar S; Martins I; Opolon P; Checcoli A; Delaune A; Robil N; de la Grange P; Hamroune J; Letourneur F; Autret G; Leung PSC; Gershwin ME; Zhu JS; Kurth MJ; Lekbaby B; Augustin J; Kim Y; Gujar S; Coulouarn C; Fouassier L; Zitvogel L; Piaggio E; Housset C; Soussan P; Maiuri MC; Kroemer G; Pol JG
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34495298
[TBL] [Abstract][Full Text] [Related]
19. The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Bissonnette RP; Cesario RM; Goodenow B; Shojaei F; Gillings M
BMC Cancer; 2021 Aug; 21(1):969. PubMed ID: 34461854
[TBL] [Abstract][Full Text] [Related]
20. The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling.
Xu L; Fang Q; Miao Y; Xu M; Wang Y; Sun L; Jia X
Bioengineered; 2021 Dec; 12(1):3467-3484. PubMed ID: 34251980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
